The reported prevalence of interstitial lung disease in patients with rheumatoid arthritis has varied from 10% to 50%, yet less than 5% of patients with arthritis develop
cells/ml. Total T lymphocytes and T lymphocyte subsets were analysed by fluorescent microscopy, murine monoclonal antibodies being used.'4 Differential counts of lymphocytes, macrophages, and neutrophils were performed on Wright-Giemsa stained cell smears by a second observer. Where there was a difference between the methods of over 10%o for the percentage of lymphocytes an esterase stained smear was used to distinguish small macrophages from large lymphocytes.
ANALYSIS OF LAVAGE FLUID
Before analysis fluid was centrifuged at 1000 g for 15 minutes, phenylmethylsulphonylfluoride (PMSF, final concentration 01 mmol/l) was added to prevent protease digestion, and the solution was concentrated 20 fold by ultrafiltration in CF25 Centriflo membrane cones (Amicon Corporation, Danvers, USA). Average protein recovery after concentration was 73 20°(n = 20, coefficient of variation = 180o). Fluid was analysed for collagenase, procollagen peptide, fibronectin, protein, and urea.'4 '9 As no satisfactory reference component for normalising lavage fluid proteins is available,20 concentrations of collagenase, procollagen peptide, and fibronectin were calculated per ml of lavage fluid, per mg of bronchoalveolar lavage protein, and per ,ug of bronchoalveolar lavage urea. '4 Only where differences between groups were statistically significant for all three calculations were they accepted as being truly significant.
SUBSTRATE SPECIFICITY OF BRONCHOALVEOLAR LAVAGE COLLAGENASE
For investigating the substrate specificity of lavage fluid collagenase, samples containing collagenase were pooled and assessed for their ability to digest radiolabelled type I (specific activity 3 x 105 cpm) and type III (specific activity 8-4 x I05 cpm) collagen. Assay of type III collagen digestion was the same as for type I collagen'4 except that all incubations were carried out for 24 hours. In addition, digestion of both types of collagen was performed at 25°C and digestion products were analysed by SDSpolyacrylamide gel electrophoresis. related to interstitial lung disease or its treatment. Corticosteroid alone (n = 4) or corticosteroid plus azothiaprine (n = 3) had not produced a sustained improvement in any patient. The addition of cyclophosphamide in one patient and methotrexate in another was associated with some improvement in pulmonary symptoms (table 3) . Bronchoalveolar lavage results from both groups of patients were compared with those from the 15 control subjects. Cellular analyses (table 4) showed no differences between the control and the rheumatoid arthritis group in the proportion of T lymphocytes recovered or the T cell phenotype. The proportion of neutrophils recovered was significantly greater in the patients with rheumatoid arthritis and established interstitial lung disease than in the control subjects. Only two patients with subclinical disease had abnormal cell counts (table  1) . One (patient 9) had a raised neutrophil count (43% of inflammatory cells); the other (patient 2) had an increased proportion of T lymphocytes (52% of inflammatory cells).
The volume of bronchoalveolar lavage fluid recovered (table 4) was smaller in both rheumatoid arthritis groups. Patients with rheumatoid arthritis also had greater protein concentrations than control subjects; urea concentrations were similar in the three groups. Patients with established interstitial lung disease had a greater procollagen peptide concentration (p < 0 02) and collagenase activity (p < 0-01) in the lavage fluid than either the control group or those with subclinical disease (figure). These differences remained when results were expressed per mg of protein or per jug of urea in the lavage fluid. In patients with established interstitial lung disease collagenase activity and procollagen peptide concentration were positively correlated (r = 0-64, p < 005, Spearman rank test). Only one patient with established interstitial lung disease (patient 9, table 3) had no detectable levels of either lavage fluid 14 patients with subclinical lung disease. An association between the presence of subclinical interstitial disease and a history of cigarette smoking was observed. In addition, 10 of the 11 patients with rheumatoid arthritis and established interstitial lung disease were current smokers or ex-smokers. Previous studies have also shown that current smokers with rheumatoid arthritis have a higher incidence of pulmonary 
